This week on The Pharmcast, we discuss areas often overlooked in due diligence efforts that can lead to expensive or even show-stopper surprises once the acquisition is complete and later development and commercial efforts are underway, with two former Johnson & Johnson medical devices executives, Donna Godward and Dr. Janet Vargo. Understanding what to look for (or present) during due diligence will reduce risks and lead to a better evaluation for the transaction.
Image may be NSFW.Clik here to view.
